Ultralife (NASDAQ:ULBI) Director Buys 28,588 Shares

Ultralife Corporation (NASDAQ:ULBI) Director Bradford Whitmore bought 28,588 shares of the firm’s stock in a transaction that occurred on Tuesday, December 16th. The stock was purchased at an average cost of $5.70 per share, with a total value of $162,951.60. Following the completion of the transaction, the director owned 1,235,631 shares in the company, valued at approximately $7,043,096.70. This trade represents a 2.37% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Ultralife Stock Performance

Shares of ULBI stock traded up $0.04 during trading hours on Tuesday, hitting $5.79. The stock had a trading volume of 75,026 shares, compared to its average volume of 70,149. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.99 and a quick ratio of 1.42. The firm has a market capitalization of $96.40 million, a PE ratio of 57.90 and a beta of 0.88. The stock’s 50 day moving average is $6.19 and its 200 day moving average is $7.11. Ultralife Corporation has a twelve month low of $4.07 and a twelve month high of $9.52.

Ultralife (NASDAQ:ULBI) last posted its quarterly earnings data on Monday, November 17th. The technology company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.28). The business had revenue of $43.37 million during the quarter, compared to analyst estimates of $53.00 million. Ultralife had a net margin of 0.92% and a return on equity of 1.66%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ULBI. Janney Montgomery Scott LLC raised its stake in Ultralife by 1.1% during the second quarter. Janney Montgomery Scott LLC now owns 446,250 shares of the technology company’s stock worth $4,007,000 after purchasing an additional 5,000 shares during the period. Truffle Hound Capital LLC acquired a new stake in shares of Ultralife during the 2nd quarter worth $2,245,000. RBF Capital LLC purchased a new position in shares of Ultralife in the 2nd quarter worth $2,020,000. Arrowstreet Capital Limited Partnership boosted its holdings in Ultralife by 210.8% in the third quarter. Arrowstreet Capital Limited Partnership now owns 219,018 shares of the technology company’s stock valued at $1,494,000 after acquiring an additional 148,542 shares during the last quarter. Finally, Raymond James Financial Inc. boosted its holdings in Ultralife by 14.5% in the second quarter. Raymond James Financial Inc. now owns 116,085 shares of the technology company’s stock valued at $1,042,000 after acquiring an additional 14,667 shares during the last quarter. 30.68% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently commented on ULBI. Wall Street Zen cut Ultralife from a “strong-buy” rating to a “hold” rating in a report on Saturday, September 13th. Weiss Ratings restated a “sell (d+)” rating on shares of Ultralife in a research report on Monday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.